Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2012
07/12/2012US20120178909 Novel Screening Strategies for the Identification of Binders
07/12/2012US20120178908 Targeting tissue factor to activated platelets
07/12/2012US20120178184 T cell proteins and nucleotides encoding the same
07/12/2012US20120178183 Mass Dots: Nanoparticle Isotope Tags
07/12/2012US20120178163 Novel tumor necrosis factor receptor homologs and nucleic acids encoding the same
07/12/2012US20120178116 Polypeptides for identifying fungicidally active compounds
07/12/2012US20120178113 Detection of igfbp-4 fragments as a diagnostic method
07/12/2012US20120178107 HUMAN ANTIBODIES THAT BIND HUMAN TNFalpha
07/12/2012US20120178086 Reductive release probes containing a chemoselectively cleavable alpha-azidoether linker and methods of use thereof
07/12/2012US20120178083 SPECIFIC MARKER Lmx1a ON DOPAMINERGIC NEURONS
07/12/2012US20120178079 Human Bocavirus and Methods of Diagnosis and Treatment
07/12/2012US20120177704 Crystalline anti-human il-12 antibodies
07/12/2012US20120177669 Phosphopeptides as melanoma vaccines
07/12/2012US20120177664 Antibodies That Specifically Bind to A Beta Oligomers and Use Thereof
07/12/2012US20120177663 Therapeutic Monoclonal Antibodies that Neutralize Botulinum Neurotoxins
07/12/2012US20120177662 Alpha-4-beta-7 heterodimer specific antagonist antibody
07/12/2012US20120177661 Human diacylglycerol acyltransferase 2 (dgat2) family members and uses therefor
07/12/2012US20120177659 Methods and compositions for treating and diagnosing diseases
07/12/2012US20120177655 Anti-human il-21 monoclonal antibodies
07/12/2012US20120177654 Method of treatment and agents useful for same
07/12/2012US20120177653 Antibodies that bind both il-17a and il-17f and methods of using the same
07/12/2012US20120177652 Bispecific binding agents for modulating biological activity
07/12/2012US20120177651 Antigen-binding proteins
07/12/2012US20120177645 Methods and compositions for the inhibition of transplant rejection
07/12/2012US20120177643 Human cdr-grafted antibody and antibody fragment thereof
07/12/2012US20120177639 Humanized antibodies specific to the protofibrillar form of the beta-amyloid peptide
07/12/2012US20120177638 Antibodies to vla-1
07/12/2012US20120177637 Method for selecting a single cell expressing a heterogeneous combination of antibodies
07/12/2012US20120177596 METHODS OF ADMINISTERING ANTI-TNFalpha ANTIBODIES
07/12/2012US20120177575 Fas (apo-1,cd95) targeted platforms for intracellular drug delivery
07/12/2012US20120177568 Novel meditopes and related meditope-monoclonal antibody delivery systems, synthesis and therapeutic uses thereof
07/12/2012DE102011008153A1 Preparing monoclonal antibody comprises immunizing mice with alpha synuclein peptide, removing and fusing B-lymphocytes with myeloma cell line, selecting fusion product peptide in cell culture vessel, selecting immunoglobulin and isolating
07/12/2012CA2824277A1 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
07/12/2012CA2823776A1 Plasma kallikrein binding proteins
07/12/2012CA2823104A1 Ligands that bind tgf-beta receptor ii
07/12/2012CA2822775A1 Modulators of il-12 and/or il-23 for the prevention or treatment of alzheimer's disease
07/12/2012CA2821646A1 Alphabodies specifically binding to cytokines or growth factors and/or cytokine or growth factor receptors
07/12/2012CA2821579A1 Alphabody libraries and methods for producing the same
07/11/2012EP2474632A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474631A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474630A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
07/11/2012EP2474558A1 New antibiotic containing simulacrum antibody, preparation method and application thereof
07/11/2012EP2474557A2 Anti-CD79b antibodies and immunoconjugates and methods of use
07/11/2012EP2474556A2 APCDD1 inhibitors for treating, diagnosing or detecting cancer
07/11/2012EP2474322A1 Products for prophylaxis and/or treatment of viral diseases and method of making and using same
07/11/2012EP2474311A2 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
07/11/2012EP2473532A1 Affinity-matured humanized anti cea monoclonal antibodies
07/11/2012EP2473531A1 Anti-gitr antibodies
07/11/2012EP2473530A1 Monoclonal antibodies against gonadotropin-releasing hormone receptor
07/11/2012EP2473529A1 Clec14a inhibitors
07/11/2012EP2473527A1 Stable formulations of polypeptides and uses thereof
07/11/2012EP2473526A1 Treatment of vasculoproliferative conditions
07/11/2012EP2473525A2 Monoclonal antibodies against glycoprotein of ebola sudan boniface virus
07/11/2012EP2473524A2 Dual variable domain immunoglobulins and uses thereof
07/11/2012EP2473523A2 Methods and compositions for the inhibition of transplant rejection
07/11/2012EP2473521A2 B7-h4 fusion proteins and methods of use thereof
07/11/2012EP2473191A1 Antibody coformulations
07/11/2012EP2473186A1 Bispecific immunocytokine dock-and-lock (dnl) complexes and therapeutic use thereof
07/11/2012EP2233501B1 Humanized anti-cd34 monoclonal antibody, the preparation and uses thereof
07/11/2012EP1960434B1 Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1
07/11/2012EP1259547B1 High potency recombinant antibodies and method for producing them
07/11/2012CN202315782U 一种磁力搅拌子 A magnetic stirring bar
07/11/2012CN1882605B Improved expression systems using Sec-system secretion
07/11/2012CN1415016B Trichoderma reesei木聚糖酶 Trichoderma reesei xylanase
07/11/2012CN102575300A CSTF2 for target genes of lung cancer therapy and diagnosis
07/11/2012CN102575283A Diagnosis and treatment of cell proliferation and differentiation disorders based on the FMN 2 gene
07/11/2012CN102574927A Hybridoma producing anti-methylated DNA antibody and utilization of same
07/11/2012CN102574926A MUC1 antibodies
07/11/2012CN102574925A Oncofetal antigen/immature laminin receptor antibodies for diagnostic and clinical applications
07/11/2012CN102574924A Anti-gitr antibodies
07/11/2012CN102574923A High affinity human antibodies to human protease-activated receptor-2
07/11/2012CN102574922A Anti - TGF - BETA receptor type II single domain antibodies
07/11/2012CN102574921A Bispecific death receptor agonistic antibodies
07/11/2012CN102574920A Treatment of autoimmune and inflammatory diseases with epratuzumab
07/11/2012CN102574919A Antibodies specifically binding to the epidermal growth factor receptor
07/11/2012CN102574918A Therapeutic agents for the treatment of diseases associated with undesired cell proliferation
07/11/2012CN102574917A Pharmaceutical composition containing anti-HB-EGF antibody as active ingredient
07/11/2012CN102574916A Human recombinant monoclonal antibody that specifically binds to VCAM-1 and inhibits adhesion and transmigration between leukocytes and endothelial cells
07/11/2012CN102574915A Antibodies that specifically bind to A beta oligomers and use thereof
07/11/2012CN102574914A Improved anti-serum albumin binding single variable domains
07/11/2012CN102574913A Multistep final filtration
07/11/2012CN102574912A Pre-filtration adjustment of buffer solutes
07/11/2012CN102574911A Methods for purifying a target protein from one or more impurities in a sample
07/11/2012CN102574910A Antibody composition with altered fab sialylation
07/11/2012CN102574908A Targeting tissue factor to activated platelets
07/11/2012CN102574026A Separation system and method
07/11/2012CN102573922A Targeted immunoconjugates
07/11/2012CN102573893A Cardiovascular related uses of IL-1beta antibodies and binding fragments thereof
07/11/2012CN102559689A Prawn complement 1q binding protein and application thereof
07/11/2012CN102559644A Antidotes for factor XA inhibitors and methods of using the same
07/11/2012CN102559606A A16 type strain of Coxsackie virus and application of the strain
07/11/2012CN102559605A Orf virus protein ORFV059 monoclonal antibody hybridoma A3 and monoclonal antibody
07/11/2012CN102559604A Monoclonal antibody having antagonistic action on HMGB1 B box and application thereof
07/11/2012CN102559603A Hybridoma cell strain capable of secreting tomato yellow leaf curl virus monoclonal antibody and application of monoclonal antibody
07/11/2012CN102559602A Monoclonal antibody hybridoma cell line for secreting southern rice black-streaked dwarf resistant viruses and monoclonal antibody application thereof
07/11/2012CN102559601A CREPT (Cell-cycle Related and Expression-elevated Protein in Tumor) antibody for identifying tumor cells or tumor tissues
07/11/2012CN102558355A Heterodimeric FC (fragment crystallizable) modification method based on charge network and preparation method of heterodimeric proteins
07/11/2012CN102558354A Human-mouse chimeric monoclonal antibody against human platelet membrane glycoprotein Ib alpha and applications of human-mouse chimeric monoclonal antibody
07/11/2012CN102558353A Escherichia coli NrfA gene expression protein polyclonal antibody and preparation method thereof
07/11/2012CN102558352A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
1 ... 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 ... 1494